32 In a simulated age-matching allocation system, the reallocatio

32 In a simulated age-matching allocation system, the reallocation of donor kidneys ≥ 65 years from younger recipients < 65 years (old-to-young) to older

recipients ≥65 years (old-to-old) would result in a decrease in 10 year graft survival from 21% to 13% (P < 0.001), whereas reallocation of donor kidneys <65 years from recipients ≥65 years (young-to-old) to younger recipients <65 years (young-to-young) would result in an improvement in 10 year graft survival (19–26%, P = 0.40). In this study, there was 3-deazaneplanocin A ic50 no net benefit of implementing an old-for-old allocation system with regards to overall functional graft years (Table 2). In Australia, the utilization of older donors has steadily grown over the years, with donors aged ≥55 years increasing from 134 in 2001–2003 to 241 in 2007–2009 (i.e. an increase from 12% to 34% of overall donors).7 We have previously reported a simulated age-matching allocation system and its impact on graft outcomes. Using the Cetuximab ANZDATA registry database, we compared total functioning graft years of current deceased donor allocation system with a model based on age-matching.31 Of the 4616

renal transplant recipients between 1991 and 2006, 70% were aged <55 years at time of transplantation. Consistent with other studies, we found that recipients ≥55 years had more than a 2.5-fold increase in death with functioning graft compared with recipients <55 years (HR 2.84, 95% CI 1.97, 4.10 for 0–1 year; HR 2.78, 95% CI 2.19, 3.53 for 1–8 years and HR 4.44, 95% CI 3.10, 6.35 for >8 years; all P-values < 0.01) (Fig. 1). Risk of early (<1 year) and late (>8 years) death-censored graft failure

was similar in recipients aged <55 years and ≥55 years. Grafts from donors ≥60 years were associated with a >50% increased risk of death censored graft failure and death with functioning graft, for the period between 1 and 8 years post-transplant. Older recipients had lower rates of rejection, which may partially explain the better creatinine at 1 and 5 years. ioxilan In contrast, grafts from older donors were associated with a significant increase in mean serum creatinine at 1 and 5 years, with a greater negative impact on renal function in younger compared with older recipients (young recipient/old donor pairs +37 µmol/L and +38 µmol/L at 1 and 5 years post-transplant compared with old recipient/old donor pairs +18 µmol/L and +26 µmol/L at 1 and 5 years post-transplant; reference group young recipient/young donor pairs). The application of an age-matching allocation model to the same cohort of 4616 transplants, whereby all younger donor kidneys were allocated to younger recipients and older donor kidneys were allocated to older recipients would result in an additional 262 mean functioning graft years, which would equate to $11.8–21.7 million savings in dialysis cost (cost per patient per year on dialysis $45 000–83 000).

Comments are closed.